212 related articles for article (PubMed ID: 27976637)
1. Thromboembolic events in patients with inflammatory bowel disease.
Algahtani FH; Farag YM; Aljebreen AM; Alazzam NA; Aleem AS; Jabri FF; Rajab MH; Shoukri MM
Saudi J Gastroenterol; 2016 Nov; 22(6):423-427. PubMed ID: 27976637
[TBL] [Abstract][Full Text] [Related]
2. The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study.
Bernstein CN; Blanchard JF; Houston DS; Wajda A
Thromb Haemost; 2001 Mar; 85(3):430-4. PubMed ID: 11307809
[TBL] [Abstract][Full Text] [Related]
3. Thromboembolic risk among Danish children and adults with inflammatory bowel diseases: a population-based nationwide study.
Kappelman MD; Horvath-Puho E; Sandler RS; Rubin DT; Ullman TA; Pedersen L; Baron JA; Sørensen HT
Gut; 2011 Jul; 60(7):937-43. PubMed ID: 21339206
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory bowel disease increases the risks of deep vein thrombosis and pulmonary embolism in the hospitalized patients: a nationwide cohort study.
Chung WS; Lin CL; Hsu WH; Kao CH
Thromb Res; 2015 Mar; 135(3):492-6. PubMed ID: 25596768
[TBL] [Abstract][Full Text] [Related]
5. Clinical presentation of venous thromboembolism in inflammatory bowel disease.
Papay P; Miehsler W; Tilg H; Petritsch W; Reinisch W; Mayer A; Haas T; Kaser A; Feichtenschlager T; Fuchssteiner H; Knoflach P; Vogelsang H; Platzer R; Tillinger W; Jaritz B; Schmid A; Blaha B; Dejaco C; Sobala A; Weltermann A; Eichinger S; Novacek G
J Crohns Colitis; 2013 Oct; 7(9):723-9. PubMed ID: 23127785
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and risk factors for venous thromboembolic complications in the Swiss Inflammatory Bowel Disease Cohort.
Alatri A; Schoepfer A; Fournier N; Engelberger RP; Safroneeva E; Vavricka S; Biedermann L; Calanca L; Mazzolai L;
Scand J Gastroenterol; 2016 Oct; 51(10):1200-5. PubMed ID: 27211077
[TBL] [Abstract][Full Text] [Related]
7. Thromboembolism in inflammatory bowel disease: results from a prospective, population-based European inception cohort.
Isene R; Bernklev T; Høie O; Langholz E; Tsianos E; Stockbrügger R; Odes S; Småstuen M; Moum B;
Scand J Gastroenterol; 2014 Jul; 49(7):820-5. PubMed ID: 24754745
[TBL] [Abstract][Full Text] [Related]
8. The increasing incidence of thromboembolic events among hospitalized patients with inflammatory bowel disease.
Kuy S; Dua A; Chappidi R; Seabrook G; Brown KR; Lewis B; Rossi PJ; Lee CJ
Vascular; 2015 Jun; 23(3):260-4. PubMed ID: 24986868
[TBL] [Abstract][Full Text] [Related]
9. Thromboembolic Events in Hospitalized Patients with Inflammatory Bowel Disease.
Nelson AD; Fluxá D; Caldera F; Farraye FA; Hashash JG; Kröner PT
Dig Dis Sci; 2023 Jun; 68(6):2597-2603. PubMed ID: 37027107
[TBL] [Abstract][Full Text] [Related]
10. Increased risk of postoperative deep vein thrombosis and pulmonary embolism in patients with inflammatory bowel disease: a study of National Surgical Quality Improvement Program patients.
Merrill A; Millham F
Arch Surg; 2012 Feb; 147(2):120-4. PubMed ID: 22006853
[TBL] [Abstract][Full Text] [Related]
11. Therapy insight: Vascular complications in patients with inflammatory bowel disease.
Koutroubakis IE
Nat Clin Pract Gastroenterol Hepatol; 2005 Jun; 2(6):266-72. PubMed ID: 16265230
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of venous thromboembolism and coagulation-fibrinolysis markers in Japanese patients with inflammatory bowel disease.
Sonoda K; Ikeda S; Mizuta Y; Miyahara Y; Kohno S
J Gastroenterol; 2004 Oct; 39(10):948-54. PubMed ID: 15549447
[TBL] [Abstract][Full Text] [Related]
13. [Risk of thromboembolic phenomena in patients with inflammatory bowel disease].
Suárez Ferrer C; Vera Mendoza MI; Amo San Román L; González Lama Y; Calvo Moya M; García Casas M; Abreu García L
Gastroenterol Hepatol; 2012 Nov; 35(9):634-9. PubMed ID: 23036695
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of lower extremity venous disease in inflammatory bowel disease.
Gosk-Bierska I; McBane RD; Waszczuk E; Paradowski L; Wysokinski WE
Int Angiol; 2007 Mar; 26(1):67-71. PubMed ID: 17353891
[TBL] [Abstract][Full Text] [Related]
15. Presenting features of childhood-onset inflammatory bowel disease in the central region of Saudi Arabia.
El Mouzan MI; Al Mofarreh MA; Assiri AM; Hamid YH; Al Jebreen AM; Azzam NA
Saudi Med J; 2012 Apr; 33(4):423-8. PubMed ID: 22485239
[TBL] [Abstract][Full Text] [Related]
16. [Prevalence and risk factors of thromboembolic complications in inflammatory bowel disease].
Said Y; Hamzaoui L; El Jeri K; Debbeche R; Trabelsi S; Moussa A; Bouzaidi S; Salem M; Guermazi S; Najjar T
Tunis Med; 2011 Dec; 89(12):924-8. PubMed ID: 22198895
[TBL] [Abstract][Full Text] [Related]
17. Thromboembolic events and cardiovascular mortality in inflammatory bowel diseases: a meta-analysis of observational studies.
Fumery M; Xiaocang C; Dauchet L; Gower-Rousseau C; Peyrin-Biroulet L; Colombel JF
J Crohns Colitis; 2014 Jun; 8(6):469-79. PubMed ID: 24183231
[TBL] [Abstract][Full Text] [Related]
18. Thromboembolic events in inflammatory bowel disease.
Mrabet S; Elleuch N; Slama AB; Jaziri H; Hammami A; Braham A; Ajmi S; Ksiaa M; Jmaa A
J Med Vasc; 2020 Apr; 45(2):67-71. PubMed ID: 32265017
[TBL] [Abstract][Full Text] [Related]
19. Persistent antiphospholipid antibody (aPL) in asymptomatic carriers as a risk factor for future thrombotic events: a nationwide prospective study.
Mustonen P; Lehtonen KV; Javela K; Puurunen M
Lupus; 2014 Dec; 23(14):1468-76. PubMed ID: 25164304
[TBL] [Abstract][Full Text] [Related]
20. Risk of arterial thrombotic events in inflammatory bowel disease.
Ha C; Magowan S; Accortt NA; Chen J; Stone CD
Am J Gastroenterol; 2009 Jun; 104(6):1445-51. PubMed ID: 19491858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
